Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Biying Biotechnology is a Chinese medical technology company specializing in the development and application of 3D printing for orthopedic external fixation. Founded in 2018 and headquartered in Wuhan, the company has developed the world's first 3D instant printing system for orthopedic supports, significantly reducing the production time for customized braces from several hours to approximately 20 minutes. Their technology utilizes starch-based powder materials and handheld 3D scanners to create personalized, breathable, and lightweight fixation devices that replace traditional plaster casts. Biying Biotechnology integrates research, design, and manufacturing to provide clinical solutions for fracture healing and rehabilitation across a network of over a hundred hospitals in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biying Chen.